RoE Newborn Screening Market to 2032
Overview
The RoE Newborn Screening Market is expected to reach a 8.39 USD Billion by 2032 and is projected to grow at a CAGR of 8.99% from 2025 to 2032.
Revenue, 2024 (USD Billion)
4.91
Forecast, 2032 (USD Billion)
8.39
CAGR, 2024 - 2032
8.99%
Report Coverage
RoE
RoE Newborn Screening Market 2018-2032 USD Billion
RoE Newborn Screening Market , Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 4.91 USD Billion
- Projected Market Size (2032): 8.39 USD Billion
- CAGR (2025-2032): 8.99%
Key Findings of RoE Newborn Screening Market
- The RoE Newborn Screening Market was valued at 4.91 USD Billion in 2024.
- The RoE Newborn Screening Market is likely to grow at a CAGR of 8.99% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Hospital in End User Segment accounted for the largest share of the market with a revenue of 3.58 USD Billion
- The fastest growing segment Hearing Screen Test in Test Type Segment grew Fastest with a CAGR of 9.72% during the forecast period from 2024 to 2032.
RoE Newborn Screening Market Scope
RoE Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
RoE Newborn Screening Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 4.91 USD Billion |
| Market Value in 2032 | 8.39 USD Billion |
| CAGR (2025-2032) | 8.99% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Technology,Disease Type,Product Type,Test Type,End User |
Regional Insights:
-
Leading Market (2024-2032): RoE, leading in terms of revenue 4.91 USD Billion in 2024
- Key Country: RoE, leading in terms of revenue with value of 4.91 USD Billion in 2024.
Segments and Scope
-
RoE Newborn Screening Market to 2032, By Technology
- Tandem Mass Spectrometry is the largest segment in RoE Newborn Screening Market to 2032 with a revenue of 1.43 USD Billion in the year 2024.
- Tandem Mass Spectrometry is the Fastest growing segment in RoE Newborn Screening Market to 2032 with a Growth rate of 9.54 % in forecast period 2025-2032.
-
RoE Newborn Screening Market to 2032, By Disease Type
- Critical Congenital Heart Diseases is the largest segment in RoE Newborn Screening Market to 2032 with a revenue of 3.30 USD Billion in the year 2024.
- Critical Congenital Heart Diseases is the Fastest growing segment in RoE Newborn Screening Market to 2032 with a Growth rate of 9.38 % in forecast period 2025-2032.
-
RoE Newborn Screening Market to 2032, By Product Type
- Instruments is the largest segment in RoE Newborn Screening Market to 2032 with a revenue of 3.39 USD Billion in the year 2024.
- Instruments is the Fastest growing segment in RoE Newborn Screening Market to 2032 with a Growth rate of 9.24 % in forecast period 2025-2032.
-
RoE Newborn Screening Market to 2032, By Test Type
- Dried Blood Spot Test is the largest segment in RoE Newborn Screening Market to 2032 with a revenue of 2.32 USD Billion in the year 2024.
- Hearing Screen Test is the Fastest growing segment in RoE Newborn Screening Market to 2032 with a Growth rate of 8.71 % in forecast period 2025-2032.
-
RoE Newborn Screening Market to 2032, By End User
- Hospital is the largest segment in RoE Newborn Screening Market to 2032 with a revenue of 3.58 USD Billion in the year 2024.
- Hospital is the Fastest growing segment in RoE Newborn Screening Market to 2032 with a Growth rate of 9.30 % in forecast period 2025-2032.
RoE Newborn Screening Market Company Share Analysis
RoE Newborn Screening Market Geographical Sales Distribution, 2018-2032 USD Billion
RoE Newborn Screening Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The RoE Newborn Screening Market is segmented based on Segmentation Technology,Disease Type,Product Type,Test Type,End User.
RoE Newborn Screening Market was valued at USD 4.91(Revenue in USD Billion) in 2022.
RoE Newborn Screening Market is projected to grow at a CAGR of 8.99% during the forecast period of 2024 to 2032.
The Hospital segment is expected to dominate the RoE Newborn Screening Market , holding a largest market share of 3.58 USD Billion in 2024
RoE Newborn Screening Market Scope
RoE Newborn Screening Market Segmentation & Scope
Technology
- DNA-Based Assays
- Electrophoresis
- Immunoassays and Enzymatic Assays
- Pulse Oximetry Screening Technology
- Hearing Screen Technology
- Tandem Mass Spectrometry
Disease Type
- Others
- Maple Syrup Urine Disease
- Phenylketonuria (PKU)
- Cystic Fibrosis (CF)
- Sickle Cell Disease
- Newborn Hearing Loss
- Critical Congenital Heart Diseases
Product Type
- Reagents and Assay Kits
- Instruments
Test Type
- Critical Congenital Heart Diseases (CCHD) Test
- Hearing Screen Test
- Dried Blood Spot Test
End User
- Clinics
- Pediatric Clinics
- Hospital
Frequently Asked Questions
The RoE Newborn Screening Market is segmented based on Segmentation Technology,Disease Type,Product Type,Test Type,End User.
RoE Newborn Screening Market was valued at USD 4.91(Revenue in USD Billion) in 2022.
RoE Newborn Screening Market is projected to grow at a CAGR of 8.99% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Newborn Screening Market for final year is USD 8.39 (USD Billion).
RoE Newborn Screening Market Company Profiling
Frequently Asked Questions
The RoE Newborn Screening Market is segmented based on Segmentation Technology,Disease Type,Product Type,Test Type,End User.
RoE Newborn Screening Market was valued at USD 4.91(Revenue in USD Billion) in 2022.
RoE Newborn Screening Market is projected to grow at a CAGR of 8.99% during the forecast period of 2024 to 2032.
The estimated market value of the RoE Newborn Screening Market for final year is USD 8.39 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.